Mabanta, Jimmy C.
HRN: 20-80-81 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2025
CEFTAZIDIME 1GM (VIAL)
07/30/2025
08/05/2025
IV
1g
Q8h
CAPMR
Checking Initial Appropriateness
07/30/2025
AZITHROMYCIN 500MG TABLET (TAB)
07/30/2025
08/03/2025
PO
500mg
OD
CAPMR
Checking Initial Appropriateness
08/08/2025
CEFIXIME 200MG (CAP)
08/08/2025
08/15/2025
PO
200 Mg
Q12 Hrs
TB Bronchiectasis
Checking Initial Appropriateness